Ersoy Betül, Yücetürk Ali Vefa, Taneli Fatma, Urk Vildan, Uyanik Bekir Sami
Celal Bayar University, Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology, Manisa, Turkey.
Int J Pediatr Otorhinolaryngol. 2005 Sep;69(9):1175-81. doi: 10.1016/j.ijporl.2005.02.020.
Adenotonsillar hypertrophy (ATH) is associated with growth interruption during childhood. The aim of this study was to determine the changes in growth, body composition and biochemical markers associated with growth following adenotonsillectomy (A&T) in prepubertal children.
Twenty-eight children aged 3-10 years (mean age 73.90 +/- 20.97 months) with ATH were followed up for 1 year after A&T. During the same period of time, 20 healthy children of similar ages (mean age 73.7 +/- 18.2 months) were followed up too.
Height, weight as well as insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) were measured during the preoperative period, 6 months and 1 year after surgery.
Height and weight of the patient group significantly increased during the first year after A&T (p < 0.01). Increase in height standard deviation score (SDS) during the first postoperative year reflected a true acceleration of growth (p = 0.04). Height and weight of patients were not significantly below those of their healthy peers at the preoperative measurement. Height velocity of the patients (p = 0.118), which was similar to that of their healthy peers in the first 6 months postoperatively, was significantly higher at the end of the second 6-month period after the operation (p = 0.048). IGF-1 levels of the patient group, which were significantly lower than those of the controls preoperatively (p < 0.001), increased to similar levels 1 year after the operation. IGFBP-3 levels of the patient group increased significantly after postoperative sixth month (p = 0.002).
Although children with ATH do not have significant growth retardation, their growth rate is slower. Increase in weight and IGF-1 levels followed by the increase in height leads to an acceleration in growth rate after A&T. These results have led to the conclusion that either the levels or effect of growth hormone (GH) increase following A&T.
腺样体扁桃体肥大(ATH)与儿童期生长发育中断有关。本研究的目的是确定青春期前儿童腺样体扁桃体切除术后(A&T)生长、身体成分及与生长相关的生化标志物的变化。
28例3至10岁(平均年龄73.90±20.97个月)患有ATH的儿童在A&T术后随访1年。在同一时期,20名年龄相仿的健康儿童(平均年龄73.7±18.2个月)也进行了随访。
在术前、术后6个月和1年测量身高、体重以及胰岛素样生长因子-1(IGF-1)和胰岛素样生长因子结合蛋白-3(IGFBP-3)。
患者组的身高和体重在A&T术后第一年显著增加(p<0.01)。术后第一年身高标准差评分(SDS)的增加反映了生长的真正加速(p=0.04)。术前患者的身高和体重并不显著低于健康同龄人的身高和体重。患者的身高增长速度(p=0.118)在术后前6个月与健康同龄人相似,在术后第二个6个月结束时显著更高(p=0.048)。患者组的IGF-1水平术前显著低于对照组(p<0.001),术后1年升至相似水平。患者组的IGFBP-3水平在术后第6个月后显著增加(p=0.002)。
虽然患有ATH的儿童没有明显的生长发育迟缓,但其生长速度较慢。体重和IGF-1水平增加后身高增加导致A&T术后生长速度加快。这些结果得出结论,A&T术后生长激素(GH)的水平或作用增加。